Insider Transactions in Q2 2022 at Orasure Technologies Inc (OSUR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
James A Datin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,523
-2.68%
|
$3,046
$2.89 P/Share
|
|
Jun 27
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+9.02%
|
$11,246
$2.89 P/Share
|
|
Jun 16
2022
|
Nancy J Gagliano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,841
-4.45%
|
$23,364
$4.69 P/Share
|
|
Jun 04
2022
|
Manner Carrie Eglinton President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,140,762
+36.11%
|
$4,563,048
$4.91 P/Share
|
|
Jun 03
2022
|
Mara G. Aspinall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,745
-8.65%
|
$26,980
$4.0 P/Share
|
|
Jun 03
2022
|
Mara G. Aspinall Director |
SELL
Grant, award, or other acquisition
|
Direct |
24,983
-24.27%
|
$99,932
$4.0 P/Share
|
|
Jun 01
2022
|
Lelio Marmora Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,104
-6.37%
|
$8,416
$4.12 P/Share
|
|
May 21
2022
|
Scott Gleason Interim CFO/SVP IR |
SELL
Payment of exercise price or tax liability
|
Direct |
1,996
-2.03%
|
$9,980
$5.53 P/Share
|
|
May 16
2022
|
Michael Celano Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+19.88%
|
$123,810
$5.25 P/Share
|
|
May 16
2022
|
Michael Celano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-4.33%
|
$16,995
$5.25 P/Share
|
|
May 16
2022
|
Ronny B Lancaster Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.74%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
David Shulkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+39.56%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
David Shulkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,745
-20.65%
|
$13,725
$5.25 P/Share
|
|
May 16
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.13%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Eamonn P Hobbs Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+24.55%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Eamonn P Hobbs Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,409
-5.49%
|
$12,045
$5.25 P/Share
|
|
May 16
2022
|
Mara G. Aspinall Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+27.4%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Mara G. Aspinall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,957
-8.23%
|
$14,785
$5.25 P/Share
|
|
May 16
2022
|
Lelio Marmora Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+37.71%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Lelio Marmora Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,928
-27.43%
|
$24,640
$5.25 P/Share
|
|
May 16
2022
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+39.55%
|
$100,000
$5.25 P/Share
|
|
May 11
2022
|
Lisa Nibauer President of Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,606
-1.28%
|
$8,030
$5.05 P/Share
|
|
Apr 06
2022
|
David Shulkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,247
-14.46%
|
$13,482
$6.71 P/Share
|
|
Apr 01
2022
|
Nancy J Gagliano Director |
BUY
Grant, award, or other acquisition
|
Direct |
114,074
+41.04%
|
-
|
|
Apr 01
2022
|
Nancy J Gagliano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,392
-17.31%
|
$26,352
$6.75 P/Share
|